While Zoom's revenue continues to grow at over 300%, the stock has pulled back of late as drug manufacturers show positive early vaccine results.
from US Top News and Analysis https://ift.tt/2Vbz7wd
https://ift.tt/eA8V8J
from US Top News and Analysis https://ift.tt/2Vbz7wd
https://ift.tt/eA8V8J
Comments
Post a Comment